P&G Surges with 70-Year Dividend Streak Amid $3.8B Thorne Deal

Procter & Gamble (PG) has found itself back in focus after extending its dividend growth streak to 70 consecutive years and announcing a $3.8 billion deal for health-focused company Thorne.

The company's share price return over the past year has been relatively muted, with a decline of 3.41%, compared to its long dividend record and expansion plans.

Despite this, Procter & Gamble operates within a competitive environment but still maintains higher operating margins and a wide moat, indicating it has competitive advantages over its competitors.

Additionally, the company's return on invested capital (ROIC) is double its cost of capital, showing good capital allocation by management.